Clinical Trials

As part of our commitment to providing quality comprehensive care for patients with Sickle Cell Disease we offer opportunities for patients to enroll in clinical studies of new and innovative therapies.

Our current areas of interest include:
   Bone Marrow Transplant
   Hemoglobin substitutes
   New agents to decrease frequency of crises
   Genetic predisposition to narcotic addiction in patients with sickle cell disease
   Dental caries in patients with sickle cell disease

If you are interested in learning more about our clinical trials please contact Dr. Sophie Lanzkron (410) 502-7770.